Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,178,542 papers from all fields of science
Search
Sign In
Create Free Account
Coronary heart disease
Known as:
Coronary Disease [Disease/Finding]
, Heart Diseases, Coronary
, Coronary Heart Diseases
Expand
An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
50 relations
100 ML eptifibatide 0.75 MG/ML Injection
500 ML Hetastarch 60 MG/ML Injection
Angina Pectoris
Angina, Unstable
Expand
Broader (4)
Arteriosclerosis
Generalized Arteriosclerosis
Heart Diseases
circulatory disorders
Narrower (5)
Coronary Arteriosclerosis
Coronary artery atheroma
Left main stem disease
Non-Q wave myocardial infarction
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2020
Highly Cited
2020
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
F. Zhou
,
Ting Yu
,
+16 authors
B. Cao
The Lancet
2020
Corpus ID: 212656559
Highly Cited
2012
Highly Cited
2012
Heart disease and stroke statistics--2012 update: a report from the American Heart Association.
V. Roger
,
A. Go
,
+34 authors
M. B. Turner
Circulation
2012
Corpus ID: 38696689
Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .e3 1. About These Statistics…
Expand
Review
2004
Review
2004
C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.
J. Danesh
,
J. Wheeler
,
+6 authors
V. Gudnason
New England Journal of Medicine
2004
Corpus ID: 24116627
BACKGROUND C-reactive protein is an inflammatory marker believed to be of value in the prediction of coronary events. We report…
Expand
Highly Cited
2000
Highly Cited
2000
MORTALITY FROM CORONARY HEART DISEASE IN SUBJECTS WITH TYPE 2 DIABETES AND IN NONDIABETIC SUBJECTS WITH AND WITHOUT PRIOR MYOCARDIAL INFARCTION
Teven
,
H. M
,
+6 authors
Yörälä
2000
Corpus ID: 43281682
s of articles published since 1993. Single articles and past issues of the Journal can also be ordered for a fee through the…
Expand
Highly Cited
2000
Highly Cited
2000
Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease.
V. Schächinger
,
M. Britten
,
A. Zeiher
Circulation
2000
Corpus ID: 8064549
BACKGROUND Endothelial vasodilator dysfunction is a characteristic feature of patients at risk for coronary atherosclerosis…
Expand
Highly Cited
1998
Highly Cited
1998
Prediction of coronary heart disease using risk factor categories.
P. Wilson
,
R. D'Agostino
,
D. Levy
,
A. Bélanger
,
H. Silbershatz
,
W. Kannel
Circulation
1998
Corpus ID: 5501746
BACKGROUND The objective of this study was to examine the association of Joint National Committee (JNC-V) blood pressure and…
Expand
Highly Cited
1998
Highly Cited
1998
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.
S. Hulley
,
D. Grady
,
+4 authors
E. Vittinghoff
JAMA
1998
Corpus ID: 29298925
CONTEXT Observational studies have found lower rates of coronary heart disease (CHD) in postmenopausal women who take estrogen…
Expand
Highly Cited
1998
Highly Cited
1998
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.
A. Tonkin
,
P. Alyward
,
+96 authors
F. O'Reilly
New England Journal of Medicine
1998
Corpus ID: 24236195
BACKGROUND In patients with coronary heart disease and a broad range of cholesterol levels, cholesterol-lowering therapy reduces…
Expand
Highly Cited
1995
Highly Cited
1995
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
J. Shepherd
,
S. Cobbe
,
+5 authors
C. Packard
1995
Corpus ID: 73308660
BACKGROUND Lowering the blood cholesterol level may reduce the risk of coronary heart disease. This double-blind study was…
Expand
Highly Cited
1987
Highly Cited
1987
Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.
M. Frick
,
O. Elo
,
+7 authors
V. Manninen
New England Journal of Medicine
1987
Corpus ID: 32319998
In a randomized, double-blind five-year trial, we tested the efficacy of simultaneously elevating serum levels of high-density…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE